FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Dunnill

Research Profile

Occupations

Procedures

Living Beings

Escherichia coli

Objects

Bioreactors

Chemicals & Drugs

Phenomena

Chemical Precipitation

Organizations

Drug Industry

Concepts & Ideas

Anatomy

Cells, Cultured

Activities & Behaviors

Industry

Co-author Network

Publications

TOP 3
Chris Mason; Peter Dunnill
Assessing the value of autologous and allogeneic cells for regenerative medicine.
Chris Mason; Peter Dunnill
Quantities of cells used for regenerative medicine and some implications for clinicians and bioprocessors.
Chris Mason; Peter Dunnill
The need for a regen industry voice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Dunnill (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Chris Mason; Peter Dunnill
Assessing the value of autologous and allogeneic cells for regenerative medicine.
Regenerative medicine 2009;4(6):835-53.
2009: Chris Mason; Peter Dunnill
Quantities of cells used for regenerative medicine and some implications for clinicians and bioprocessors.
Regenerative medicine 2009;4(2):153-7.
2008: Chris Mason; Peter Dunnill
The need for a regen industry voice.
Regenerative medicine 2008;3(5):621-31.
2008: Chris Mason; Peter Dunnill
The crucial linkage required between regenerative medicine bioprocessors and clinicians.
Regenerative medicine 2008;3(4):435-42.
2008: Nigel J Titchener-Hooker; Peter Dunnill; Mike Hoare
Micro biochemical engineering to accelerate the design of industrial-scale downstream processes for biopharmaceutical proteins.
Biotechnology and bioengineering 2008;100(3):473-87.
2008: Chris Mason; Peter Dunnill
The strong financial case for regenerative medicine and the regen industry.
Regenerative medicine 2008;3(3):351-63.
2008: Chris Mason; Peter Dunnill
A brief definition of regenerative medicine.
Regenerative medicine 2008;3(1):1-5.
2007: Chris Mason; Peter Dunnill
Lessons for the nascent regenerative medicine industry from the biotech sector.
Regenerative medicine 2007;2(5):753-6.
2007: Chris Mason; Peter Dunnill
Translational regenerative medicine research: essential to discovery and outcome.
Regenerative medicine 2007;2(3):227-9.
2007: David S Fedson; Peter Dunnill
Commentary: From scarcity to abundance: pandemic vaccines and other agents for "have not" countries.
Journal of public health policy 2007;28(3):322-40.
2006: Julia F Markusen; Christopher Mason; Dearbhla A Hull; Martin A Town; Alethea B Tabor; Mark Clements; Chris Boshoff; Peter Dunnill
Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beads.
Tissue engineering 2006;12(4):821-30.
2006: Peter Dunnill
A DNA flu vaccine in practice.
Nature biotechnology 2006;24(2):139.
2005: Mike Hoare; M Susana Levy; Daniel G Bracewell; Steven D Doig; Simyee Kong; Nigel J Titchener-Hooker; John M Ward; Peter Dunnill
Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic.
Biotechnology progress 2005;21(6):1577-92.
2004: Christopher Mason; Julia F Markusen; Martin A Town; Peter Dunnill; Ruikang K Wang
Doppler optical coherence tomography for measuring flow in engineered tissue.
Biosensors & bioelectronics 2004;20(3):414-23.
2004: Christopher Mason; Julia F Markusen; Martin A Town; Peter Dunnill; Ruikang K Wang
The potential of optical coherence tomography in the engineering of living tissue.
Physics in medicine and biology 2004;49(7):1097-115.
2002: S I Harding; Andrew Afoke; Robert A Brown; A MacLeod; Parviz Ayazi Shamlou; Peter Dunnill
Engineering and cell attachment properties of human fibronectin-fibrinogen scaffolds for use in tissue engineered blood vessels.
Bioprocess and biosystems engineering 2002;25(1):53-9.
2002: J J Pierce; S C Robinson; J M Ward; Eli Keshavarz-Moore; Peter Dunnill
A comparison of the process issues in expressing the same recombinant enzyme periplasmically in Escherichia coli and extracellularly in Streptomyces lividans.
Journal of biotechnology 2002;92(3):205-15.
2002: John M Young; Peter Dunnill; Jeremy D Pearce
Separation characteristics of liquid nematode cultures and the design of recovery operations.
Biotechnology progress 2002;18(1):29-35.
2001: E G Varga; Nigel J Titchener-Hooker; Peter Dunnill
Prediction of the pilot-scale recovery of a recombinant yeast enzyme using integrated models.
Biotechnology and bioengineering 2001;74(2):96-107.
2001: S Underwood; Andrew Afoke; Robert A Brown; A J MacLeod; Parviz Ayazi Shamlou; Peter Dunnill
Wet extrusion of fibronectin-fibrinogen cables for application in tissue engineering.
Biotechnology and bioengineering 2001;73(4):295-305.
2001: G D Cooke; Rocky M Cranenburgh; Julian A J Hanak; Peter Dunnill; D R Thatcher; John M Ward
Purification of essentially RNA free plasmid DNA using a modified Escherichia coli host strain expressing ribonuclease A.
Journal of biotechnology 2001;85(3):297-304.
2000: M Susana Levy; Ronan O'Kennedy; Parviz Ayazi-Shamlou; Peter Dunnill
Biochemical engineering approaches to the challenges of producing pure plasmid DNA.
Trends in biotechnology 2000;18(7):296-305.
2000: Barry Buckland; Peter Dunnill; M D Lilly
The enzymatic transformation of water-insoluble reactants in nonaqueous solvents. Conversion of cholesterol to cholest-4-ene-3-one by a Nocardia sp. Reprinted from Biotechnology and Bioengineering, Vol. XVII, Pages 815-826 (1975).
Biotechnology and bioengineering 2000;67(6):714-9.
2000: J P Maybury; Mike Hoare; Peter Dunnill
The use of laboratory centrifugation studies to predict performance of industrial machines: studies of shear-insensitive and shear-sensitive materials.
Biotechnology and bioengineering 2000;67(3):265-73.
2000: M Susana Levy; I J Collins; J T Tsai; Parviz Ayazi Shamlou; John M Ward; Peter Dunnill
Removal of contaminant nucleic acids by nitrocellulose filtration during pharmaceutical-grade plasmid DNA processing.
Journal of biotechnology 2000;76(2-3):197-205.
1999: EB Daae; Peter Dunnill; Timothy A Mitsky; Stephen R Padgette; NB Taylor; Henry E Valentin; Kenneth J Gruys
Metabolic modeling as a tool for evaluating polyhydroxyalkanoate copolymer production in plants.
Metabolic engineering 1999;1(3):243-54.
1998: L A Ciccolini; Parviz Ayazi Shamlou; Nigel J Titchener-Hooker; John M Ward; Peter Dunnill
Time course of SDS-alkaline lysis of recombinant bacterial cells for plasmid release.
Biotechnology and bioengineering 1998;60(6):768-70.
1998: Parviz Ayazi Shamlou; Peter Dunnill; Mike Hoare; AP Ison; Eli Keshavarz-Moore; Gary J Lye; Nigel J Titchener-Hooker; Michael K Turner; John M Woodley; Barry Buckland
UCL biochemical engineering.
Biotechnology and bioengineering 1998;60(5):527-33.
1997: J J Pierce; C Turner; Eli Keshavarz-Moore; Peter Dunnill
Factors determining more efficient large-scale release of a periplasmic enzyme from E. coli using lysozyme.
Journal of biotechnology 1997;58(1):1-11.
1997: S M O'Brien; R P Sloane; O R Thomas; Peter Dunnill
Characterisation of non-porous magnetic chelator supports and their use to recover polyhistidine-tailed T4 lysozyme from a crude E. coli extract.
Journal of biotechnology 1997;54(1):53-67.
1997: J S Harrison; Eli Keshavarz-Moore; Peter Dunnill; M J Berry; A Fellinger; L Frenken
Factors affecting the fermentative production of a lysozyme-binding antibody fragment in Escherichia coli.
Biotechnology and bioengineering 1997;53(6):611-22.
1996: P E Morgan; O R Thomas; Peter Dunnill; A J Sheppard; N K Slater
Polyvinyl alcohol-coated perfluorocarbon supports for metal chelating affinity separation of a monoclonal antibody.
Journal of molecular recognition : JMR 1996;9(5-6):394-400.
1996: R P Sloane; J M Ward; S M O'Brien; O R Thomas; Peter Dunnill
Expression and purification of a recombinant metal-binding T4 lysozyme fusion protein.
Journal of biotechnology 1996;49(1-3):231-8.
1996: P Richardson; J Molloy; R Ravenhall; I Holwill; Mike Hoare; Peter Dunnill
High speed centrifugal separator for rapid on-line sample clarification in biotechnology.
Journal of biotechnology 1996;49(1-3):111-8.
1996: P Williams; Eli Keshavarz-Moore; Peter Dunnill
Production of cadmium sulphide microcrystallites in batch cultivation by Schizosaccharomyces pombe.
Journal of biotechnology 1996;48(3):259-67.
1991: Eli Keshavarz-Moore; R Olbrich; Mike Hoare; Peter Dunnill
Application of biochemical engineering principles to develop a recovery process for protein inclusion bodies.
Annals of the New York Academy of Sciences 1991;646():307-14.
1990: P Milburn; J Bonnerjea; Mike Hoare; Peter Dunnill
Selective flocculation of nucleic acids, lipids, and colloidal particles from a yeast cell homogenate by polyethyleneimine, and its scale-up.
Enzyme and microbial technology 1990;12(7):527-32.
1990: S J Osborne; J Leaver; M K Turner; Peter Dunnill
Correlation of biocatalytic activity in an organic-aqueous two-liquid phase system with solvent concentration in the cell membrane.
Enzyme and microbial technology 1990;12(4):281-91.
1989: Mike Hoare; Peter Dunnill
Biochemical engineering challenges of purifying useful proteins.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 1989;324(1224):497-507.
1983: Mike Hoare; Peter Dunnill; D J Bell
Reactor design for protein precipitation and its effect on centrifugal separation.
Annals of the New York Academy of Sciences 1983;413():254-69.
1982: P S Cheetham; Peter Dunnill; M D Lilly
The characterization and interconversion of three forms of cholesterol oxidase extracted from Nocardia rhodochrous.
The Biochemical journal 1982;201(3):515-21.
1980: M D Lilly; S W Carleysmith; Peter Dunnill
Deacylation of benzylpenicillin by immobilized penicillin acylase.
Biochimie 1980;62(5-6):317-21.